Sharif Vakili has a breadth of experience at the intersection of healthcare, entrepreneurship and academic research.
Prior to joining as an Associate of the LS Polaris Innovation Fund, Sharif had worked in Business Development for RNA therapeutics company Translate Bio and in healthcare investing for SR One, where he supported cell therapy portfolio companies NKarta and Arcellx in Corporate Strategy roles.
Sharif is also the cofounder and CFO of USMLE Pro, a medical education company. Academically, Sharif has published prolifically in clinical research and healthcare delivery. Sharif has an MBA from Harvard University, an MS in Biology from Yale University and is earning his MD from the Johns Hopkins School of Medicine.